Maintenance therapy with bacillus Calmette-Guerin in patients with superficial bladder cancer.
The effectiveness of intravesical therapy with bacillus Calmette-Guerin for the treatment of superficial bladder cancer has been well established. However, there is no consensus about the optimum regimen for administering BCG. Maintenance therapy in 28 patients, results, and complications are addressed.
Swibold
L K
LK
Veterans Affairs Medical Center, Tucson, AZ, USA.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000465:Algorithms; D001500:BCG Vaccine / Q000627:therapeutic use*; D001706:Biopsy; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000628:therapy*; D002985:Clinical Protocols; D003558:Cystoscopy; D003663:Decision Trees; D006801:Humans; D007322:Instillation, Drug; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine